Endothelial cells are a target of both complement and kinin system

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 143-147

  Bossi, Fleur ^a   Bulla, Roberta ^a   Tedesco, Francesco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

C1 inhibitor; Complement; Endothelium; gC1qR; Kinins

Indexed keywords

BLOOD CLOTTING FACTOR 12A; CELL ADHESION MOLECULE; CHEMOTACTIC FACTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; KALLIKREIN; KININ; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PLASMIN; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING; BLOOD VESSEL WALL; CELL CONTACT; CELL FUNCTION; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME REGULATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; KALLIKREIN KININ SYSTEM; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; HUMANS; KININS; MEMBRANE GLYCOPROTEINS; RECEPTORS, COMPLEMENT;

EID: 37549036284     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.006     Document Type: Article

References (61)

1. Fishelson Z., Attali G., and Mevorach D. Complement and apoptosis. Mol Immunol 38 (2001) 207-219
2. Saadi S., and Platt J.L. Endothelial cell responses to complement activation. In: Volanakis E., and Frank M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, Inc., New York 335-353
3. Morris K.M., Aden D.P., Knowles B.B., and Colten H.R. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest 70 (1982) 906-913
4. Johnson E., and Hetland G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol 27 (1988) 489-493
5. Garred P., Hetland G., Mollnes T.E., and Stoervold G. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts. Scand J Immunol 32 (1990) 555-560
6. Langeggen H., Pausa M., Johnson E., Casarsa C., and Tedesco F. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. Clin Exp Immunol 121 (2000) 69-76
7. Arlaud G.J., Colomb M.G., and Gagnon J. A novel functional model of the human complement component C1q. Immunol Today 8 (1987) 106-111
8. Strang C.J., Siegel R.C., Phillips M.L., Poon P.H., and Schumaker V.N. Ultrastructure of the first component of human complement: electron microscopy of the crosslinked complex. Proc Natl Acad Sci U S A 79 (1982) 586-590
9. Matsushita M., and Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 176 (1992) 1497-1502
10. Ji Y.H., Fujita T., Hatsuse H., Takahashi A., Matsushita M., and Kawakami M. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor. J Immunol 150 (1993) 571-578
11. Matsushita M., Endo Y., Hamasaki N., and Fujita T. Activation of the lectin complement pathway by ficolins. Int Immunopharmacol 1 (2001) 359-363
12. Reid K.B.M. C1q and mannose-binding lectin. In: Volanakis E., and Frank M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, Inc., New York 33-48
13. Pangburn M., and Muller-Eberhard H. The alternative pathway of complement. Semin Immunopathol 7 (1984) 163-192
14. Tedesco F., Bulla R., and Fischetti F. Terminal complement complex: regulation of formation and pathophysiological functions. In: DSzebeni J. (Ed). The complement system (2004), KAP 97-127
15. Bossi F., Fischetti F., Pellis V., Bulla R., Ferrero E., Mollnes T.E., et al. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. J Immunol 173 (2004) 6921-6927
16. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., et al. Functions of cell surface heparin sulfate proteoglycans. Annu Rev Biochem 68 (1999) 729-777
17. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264 (1989) 4743-4746
18. Broze Jr. G.J. Tissue factor pathway inhibitor. Thromb Haemost 74 (1995) 90-93
19. Levin E.G., Marotti K.R., and Santell L. Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA. J Biol Chem 264 (1989) 16030-16036
20. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
21. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561
22. Peerschke E.I., Malhotra R., Ghebrehiwet B., Reid K.B., Willis A.C., and Sim R.B. Isolation of a human endothelial cell C1q receptor (C1qR). J Leukoc Biol 53 (1993) 179-184
23. Peerschke E.I., Smyth S.S., Teng E.I., Dalzell M., and Ghebrehiwet B. Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. J Immunol 157 (1996) 4154-4158
24. Ghebrehiwet B., Lim B.L., Peerschke E.I., Willis A.C., and Reid K.B. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med 179 (1994) 1809-1821
25. Joseph K., Ghebrehiwet B., Peerschke E.I., Reid K.B., and Kaplan A.P. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A 93 (1996) 8552-8557
26. Herwald H., Dedio J., Kellner R., Loos M., and Muller-Esterl W. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J Biol Chem 271 (1996) 13040-13047
27. Oroszlan M., Daha M.R., Cervenak L., Prohaszka Z., Fust G., and Roos A. MBL and C1q compete for interaction with human endothelial cells. Mol Immunol 44 (2007) 1150-1158
28. Stuart G.R., Lynch N.J., Day A.J., Schwaeble W.J., and Sim R.B. The C1q and collectin binding site within C1q receptor (cell surface calreticulin). Immunopharmacology 38 (1997) 73-80
29. Malhotra R., Willis A.C., Jensenius J.C., Jackson J., and Sim R.B. Structure and homology of human C1q receptor (collectin receptor). Immunology 78 (1993) 341-348
30. Malhotra R., Thiel S., Reid K.B., and Sim R.B. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 172 (1990) 955-959
31. Ghebrehiwet B., Silvestri L., and McDevitt C. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J Exp Med 160 (1984) 1375-1389
32. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194 (2001) 781-795
33. Lozada C., Levin R.I., Huie M., Hirschhorn R., Naime D., Whitlow M., et al. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci U S A 92 (1995) 8378-8382
34. van den Berg R.H., Faber-Krol M.C., Sim R.B., and Daha M.R. The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 161 (1998) 6924-6930
35. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94 (1994) 1147-1155
36. Albrecht E.A., Chinnaiyan A.M., Varambally S., Kumar-Sinha C., Barrette T.R., Sarma J.V., et al. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164 (2004) 849-859
37. Monsinjon T., Gasque P., Chan P., Ischenko A., Brady J.J., and Fontaine M.C. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 17 (2003) 1003-1014
38. Dobrina A., Pausa M., Fischetti F., Bulla R., Vecile E., Ferrero E., et al. Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 99 (2002) 185-192
39. Schraufstatter I.U., Trieu K., Sikora L., Sriramarao P., and DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J Immunol 169 (2002) 2102-2110
40. DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., and Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162 (1999) 1127-1136
41. Tedesco F., Pausa M., Nardon E., Introna M., Mantovani A., and Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185 (1997) 1619-1627
42. Casarsa C., De Luigi A., Pausa M., De Simoni M.G., and Tedesco F. Intracerebroventricular injection of the terminal complement complex causes inflammatory reaction in the rat brain. Eur J Immunol 33 (2003) 1260-1270
43. Shariat-Madar Z., Mahdi F., and Schmaier A.H. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation. Int Immunopharmacol 2 (2002) 1841-1849
44. Davis III A.E. The pathophysiology of hereditary angioedema. Clin Immunol 114 (2005) 3-9
45. Colman R.W., Pixley R.A., Najamunnisa S., Yan W., Wang J., Mazar A., et al. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J Clin Invest 100 (1997) 1481-1487
46. Hasan A.A., Zisman T., and Schmaier A.H. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci U S A 95 (1998) 3615-3620
47. Joseph K., Ghebrehiwet B., and Kaplan A.P. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol 92 (1999) 246-255
48. Collard C.D., Montalto M.C., Reenstra W.R., Buras J.A., and Stahl G.L. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 159 (2001) 1045-1054
49. Mahdi F., Madar Z.S., Figueroa C.D., and Schmaier A.H. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99 (2002) 3585-3596
50. Shariat-Madar Z., Mahdi F., and Schmaier A.H. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 277 (2002) 17962-17969
51. Ghebrehiwet B., Silverberg M., and Kaplan A.P. Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 153 (1981) 665-676
52. Yarovaya G.A., Blokhina T.B., and Neshkova E.A. Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry (Mosc) 67 (2002) 13-24
53. Beltrani V.S. Angioedema: some new thoughts regarding idiopatic angioedema. In: Greaves M.V., and Kaplan A.P. (Eds). Urticaria and angioedema (2004), Marcel Dekker, Inc., New York 421-439
54. Davis III A.E. C1 inhibitor gene and hereditary angioedema. In: Volanakis E., and Frank M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, Inc., New York 455-480
55. Petersen S.V., Thiel S., Jensen L., Vorup-Jensen T., Koch C., and Jensenius J.C. Control of the classical and the MBL pathway of complement activation. Mol Immunol 37 (2000) 803-811
56. Jiang H., Wagner E., Zhang H., and Frank M.M. Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med 194 (2001) 1609-1616
57. Kaplan A.P. C1 inhibitor deficiency. In: Greaves M.V., and Kaplan A.P. (Eds). Urticaria and angioedema (2004), Marcel Dekker, Inc., New York 303-320
58. Ghebrehiwet B. The complement system. Mechanisms of activation, regulation and role in innate immunity. In: Greaves M.V., and Kaplan A.P. (Eds). Urticaria and angioedema (2004), Marcel Dekker, Inc., New York 73-118
59. Nussberger J., Cugno M., Amstutz C., Cicardi M., Pellacani A., and Agostoni A. Plasma bradykinin in angio-oedema. Lancet 351 (1998) 1693-1697
60. Donaldson V.H., Rosen F.S., and Bing D.H. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc Am Physicians 90 (1977) 174-183
61. D'Orleans-Juste P., de Nucci G., and Vane J.R. Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br J Pharmacol 96 (1989) 920-926